Inventor · disambiguated record
Steven M. Stirdivant
Also filed as: STIRDIVANT STEVEN M
12 granted patents·4 pending applications·177 citations·filing 1994–2023
92Inventor score
Top patents by PatentIndex Score
16 records- 0194US9970005B2RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)SIRNA THERAPEUTICS INC·Filed 2015·Granted May 15, 2018·15 cites·41 claims
- 0293US11932854B2RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)SIRNA THERAPEUTICS INC·Filed 2021·Granted Mar 19, 2024·2 cites·25 claims
- 0393US8835623B2RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2013·Granted Sep 16, 2014·15 cites·20 claims
- 0492US9260471B2RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)CANCILLA MARK·Filed 2011·Granted Feb 16, 2016·60 cites·53 claims
- 0591US11193126B2RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)SIRNA THERAPEUTICS INC·Filed 2018·Granted Dec 7, 2021·7 cites·40 claims
- 0691US8518907B2RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)BROWN DUNCAN·Filed 2011·Granted Aug 27, 2013·16 cites·17 claims
- 0789US9850491B2RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2016·Granted Dec 26, 2017·5 cites·15 claims
- 0888US2024247271A1Rna interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (ctnnb1) gene expression using short interfering nucleic acid (sina)SIRNA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0987US9447420B2RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (SINA)SIRNA THERAPEUTICS INC·Filed 2014·Granted Sep 20, 2016·6 cites·39 claims
- 1077US2023030119A1Rna interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (ctnnb1) gene expression using short interfering nucleic acid (sina)SIRNA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1171US5690928AMethod of treating bladder cancer cellsMERCK & CO INC·Filed 1994·Granted Nov 25, 1997·44 cites·20 claims
- 1268US2019330639A1Rna interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (ctnnb1) gene expression using short interfering nucleic acid (sina)SIRNA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1366US10246714B2RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2017·Granted Apr 2, 2019·0 cites·23 claims
- 1449US2016245814A1Biomarkers for kidney cancer and methods using the sameMETABOLON INC·Filed 2014·Application pending·0 cites
- 1542US5621078AModified pseudomonas exotoxin PE40MERCK & CO INC·Filed 1995·Granted Apr 15, 1997·6 cites·3 claims
- 1631US5912322AModified pseudomonas exotoxin PE40MERCK & CO INC·Filed 1997·Granted Jun 15, 1999·1 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Steven M. Stirdivant files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →